Related Experiment Videos
Interferon inducing activity of polyinosinic acid
The Journal of General Virology
|July 1, 1978
Summary
Certain polyriboinosinic acid (poly(I)) preparations effectively induce interferon, a key immune protein. These poly(I) inducers show variable efficacy across cell systems and are less stable than poly(I)·poly(C), suggesting potential clinical safety benefits.
Area of Science:
- Immunology
- Virology
- Biochemistry
Background:
- Polyriboinosinic acid (poly(I)) is typically considered inactive as an interferon inducer.
- Interferon induction is a critical component of the innate immune response against viral infections.
Purpose of the Study:
- To investigate the interferon-inducing potential of authentic polyriboinosinic acid (poly(I)) preparations.
- To compare the efficacy and stability of poly(I) with polyriboinosinic acid:polyribocytidylic acid (poly(I)·poly(C)) in various biological systems.
Main Methods:
- Assaying interferon induction in human diploid fibroblasts, rabbit kidney cell cultures, and intact rabbits.
- Evaluating interferon induction in interferon-treated and DEAE-dextran-treated mouse L cells.
- Assessing the susceptibility of poly(I) and poly(I)·poly(C) to degradation by nucleases (TI ribonuclease, pancreatic ribonuclease, human serum nucleases).
Main Results:
- Several poly(I) preparations demonstrated significant interferon-inducing activity, contrary to previous assumptions.
- Efficacy varied across cell systems, with poly(I) being nearly as effective as poly(I)·poly(C) in superinduced human fibroblasts but less effective in other systems and in vivo.
- Poly(I) was found to be more susceptible to enzymatic degradation by nucleases compared to poly(I)·poly(C).
Conclusions:
- Authentic poly(I) can function as an interferon inducer, with activity dependent on the biological system.
- The increased susceptibility of poly(I) to degradation may contribute to its variable efficacy but could also enhance its safety profile for clinical applications due to a limited half-life.